Movement Disorder Quantification Algorithm Development

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Great Lakes NeuroTechnologies Inc.
ClinicalTrials.gov Identifier:
NCT01534650
First received: February 14, 2012
Last updated: September 18, 2013
Last verified: September 2013
  Purpose

The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.


Condition
Parkinson's Disease
Essential Tremor

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Great Lakes NeuroTechnologies Inc.:

Estimated Enrollment: 100
Study Start Date: February 2012
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Residents of Northeastern Ohio with a movement disorder such as Parkinson's disease or essential tremor.

Criteria

Inclusion Criteria:

  • Aged 18 years or older
  • Clinical diagnosis of idiopathic Parkinson's disease or essential tremor
  • Able to provide informed consent

Exclusion Criteria:

  • Significant medical or psychiatric illness
  • Not capable of following the required clinical instructions
  • Serious medical conditions that compromise safety
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01534650

Locations
United States, Ohio
Great Lakes NeuroTechnologies Inc. Movement Disorders Laboratory
Valley View, Ohio, United States, 44125
Sponsors and Collaborators
Great Lakes NeuroTechnologies Inc.
Investigators
Principal Investigator: Dustin A Heldman, PhD Great Lakes NeuroTechnologies Inc.
  More Information

No publications provided

Responsible Party: Great Lakes NeuroTechnologies Inc.
ClinicalTrials.gov Identifier: NCT01534650     History of Changes
Other Study ID Numbers: GLNT-001
Study First Received: February 14, 2012
Last Updated: September 18, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Great Lakes NeuroTechnologies Inc.:
motion sensors
tremor
bradykinesia
gait
balance
dyskinesia

Additional relevant MeSH terms:
Movement Disorders
Parkinson Disease
Tremor
Essential Tremor
Central Nervous System Diseases
Nervous System Diseases
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Neurodegenerative Diseases
Dyskinesias
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on April 15, 2014